37644692|t|Intranasal neuropeptide Y1 receptor antagonism improves motor deficits in symptomatic SOD1 ALS mice.
37644692|a|OBJECTIVE: Neuropeptide Y (NPY) is a 36 amino acid peptide widely considered to provide neuroprotection in a range of neurodegenerative diseases. In the fatal motor neuron disease amyotrophic lateral sclerosis (ALS), recent evidence supports a link between NPY and ALS disease processes. The goal of this study was to determine the therapeutic potential and role of NPY in ALS, harnessing the brain-targeted intranasal delivery of the peptide, previously utilised to correct motor and cognitive phenotypes in other neurological conditions. METHODS: To confirm the association with clinical disease characteristics, NPY expression was quantified in post-mortem motor cortex tissue of ALS patients and age-matched controls. The effect of NPY on ALS cortical pathophysiology was investigated using slice electrophysiology and multi-electrode array recordings of SOD1G93A cortical cultures in vitro. The impact of NPY on ALS disease trajectory was investigated by treating SOD1G93A mice intranasally with NPY and selective NPY receptor agonists and antagonists from pre-symptomatic and symptomatic phases of disease. RESULTS: In the human post-mortem ALS motor cortex, we observe a significant increase in NPY expression, which is not present in the somatosensory cortex. In vitro, we demonstrate that NPY can ameliorate ALS hyperexcitability, while brain-targeted nasal delivery of NPY and a selective NPY Y1 receptor antagonist modified survival and motor deficits specifically within the symptomatic phase of the disease in the ALS SOD1G93A mouse. INTERPRETATION: Taken together, these findings highlight the capacity for non-invasive brain-targeted interventions in ALS and support antagonism of NPY Y1Rs as a novel strategy to improve ALS motor function.
37644692	56	70	motor deficits	Disease	MESH:D009461
37644692	86	90	SOD1	Gene	20655
37644692	91	94	ALS	Disease	MESH:D000690
37644692	112	126	Neuropeptide Y	Gene	4852
37644692	128	131	NPY	Gene	4852
37644692	219	245	neurodegenerative diseases	Disease	MESH:D019636
37644692	260	280	motor neuron disease	Disease	MESH:D016472
37644692	281	310	amyotrophic lateral sclerosis	Disease	MESH:D000690
37644692	312	315	ALS	Disease	MESH:D000690
37644692	358	361	NPY	Gene	4852
37644692	366	369	ALS	Disease	MESH:D000690
37644692	467	470	NPY	Gene	4852
37644692	474	477	ALS	Disease	MESH:D000690
37644692	616	639	neurological conditions	Disease	MESH:D019636
37644692	716	719	NPY	Gene	4852
37644692	784	787	ALS	Disease	MESH:D000690
37644692	837	840	NPY	Gene	4852
37644692	844	847	ALS	Disease	MESH:D000690
37644692	960	968	SOD1G93A	CellLine	CVCL:C0CZ
37644692	1011	1014	NPY	Gene	109648
37644692	1018	1021	ALS	Disease	MESH:D000690
37644692	1070	1078	SOD1G93A	CellLine	CVCL:C0CZ
37644692	1102	1105	NPY	Gene	109648
37644692	1248	1251	ALS	Disease	MESH:D000690
37644692	1303	1306	NPY	Gene	4852
37644692	1399	1402	NPY	Gene	109648
37644692	1418	1421	ALS	Disease	MESH:D000690
37644692	1480	1483	NPY	Gene	109648
37644692	1549	1563	motor deficits	Disease	MESH:D009461
37644692	1628	1631	ALS	Disease	MESH:D000690
37644692	1632	1640	SOD1G93A	CellLine	CVCL:C0CZ
37644692	1767	1770	ALS	Disease	MESH:D000690
37644692	1797	1800	NPY	Gene	109648
37644692	1837	1840	ALS	Disease	MESH:D000690
37644692	Negative_Correlation	MESH:D000690	109648
37644692	Association	MESH:D009461	109648
37644692	Association	MESH:D000690	4852

